| Record ID | marc_loc_2016/BooksAll.2016.part40.utf8:30103661:1527 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part40.utf8:30103661:1527?format=raw |
LEADER: 01527cam a22003737a 4500
001 2012405431
003 DLC
005 20130824080825.0
008 120627s2010 enka b 001 0 eng
010 $a 2012405431
015 $aGBB027833$2bnb
016 7 $a101549574$2DNLM
016 7 $a015489396$2Uk
020 $a9780521760584 (hardback)
020 $a0521760585 (hardback)
035 $a(OCoLC)ocn520730503
040 $aNLM$cNLM$dUKM$dBWKUK$dCDX$dIUL$dYDXCP$dEUM$dLML$dMIX$dDLC
042 $aukblcatcopy$anlmcopyc$alccopycat
050 00 $aRM332$b.N49 2010
060 00 $a2010 M-712
060 10 $aQV 77.5
082 04 $a615.788$222
245 00 $aNext generation antidepressants :$bmoving beyond monoamines to discover novel treatment strategies for mood disorders /$cedited by Chad E. Beyer and Stephen M. Stahl.
260 $aCambridge ;$aNew York :$bCambridge University Press,$c2010.
300 $axi, 137 p. :$bill. ;$c24 cm.
490 1 $aCambridge medicine
504 $aIncludes bibliographical references and index.
520 8 $aThis text looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences--$cSource other than Library of Congress.
650 0 $aAntidepressants.
650 12 $aAntidepressive Agents.
650 22 $aMood Disorders$xdrug therapy.
700 1 $aBeyer, Chad E.
700 1 $aStahl, Stephen M.,$d1951-
830 0 $aCambridge medicine.